Interview with Michael P. Gantier

Interview with Michael P. Gantier …………… Michael P. Gantier, Ph.D. Group leader, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, Melbourne Australia How did you become interested in the field of oligonucleotides? I started my Ph.D. mid 2002 at University College Dublin (UCD), at the time when siRNAs had…

Interview with Kalyan Dulla

Interview with Kalyan Dulla …………… Kalyan Dulla, PhD, MBA Director Non-Clinical Research ProQR Therapeutics How did you become interested in the field of oligonucleotides? Although I had been aware of the use of antisense oligonucleotides for (m)RNA knockdown or as aptamers since my university days I was not aware of their other applications. The field…

Interview with Daniel O’Reilly

Interview with Daniel O’Reilly …………… Daniel O’Reilly MChem, PhD Candidate McGill University How did you become interested in the field of oligonucleotides? My introduction to the world of genetic disease and oligonucleotides came at an early age when my mum was diagnosed with Huntington’s Disease (HD). Witnessing the impact of this disease on my mum…